Synlett 2017; 28(16): 2143-2146
DOI: 10.1055/s-0036-1589066
letter
© Georg Thieme Verlag Stuttgart · New York

Silver(I)-Catalyzed Deprenylation of Allylsulfonamide Derivatives

Division of Pharmaceutical Sciences, Graduate School of Medical Sciences, Kanazawa University, Kakuma-machi, Kanazawa 920-1192, Japan   eMail: finagaki@p.kanazawa-u.ac.jp
,
Shisen Hira
Division of Pharmaceutical Sciences, Graduate School of Medical Sciences, Kanazawa University, Kakuma-machi, Kanazawa 920-1192, Japan   eMail: finagaki@p.kanazawa-u.ac.jp
,
Chisato Mukai
Division of Pharmaceutical Sciences, Graduate School of Medical Sciences, Kanazawa University, Kakuma-machi, Kanazawa 920-1192, Japan   eMail: finagaki@p.kanazawa-u.ac.jp
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received: 13. Mai 2017

Accepted after revision: 30. Mai 2017

Publikationsdatum:
11. Juli 2017 (online)


Preview

Abstract

The silver(I)-catalyzed deprenylation of sulfonamide bearing prenyl functional groups on the nitrogen atom has been developed. In this reaction, the prenyl moiety was selectively eliminated without allyl or benzyl cleavage on the nitrogen atom. In addition, geranyl was also applicable for this elimination reaction. Furthermore, sulfonamide possessing two prenyl groups underwent a double deprenylation to form the corresponding deprenylated sulfonamide. Thus, a novel reactivity between the silver cation and double bond was observed.

Supporting Information